Synthesis of a new thymosin analogue and its effect on T-lymphocytes
Author Information
Author(s): Takashi Abiko, Hiroshi Sekino
Primary Institution: Kidney Research Laboratory, Kojinkai
Hypothesis
Can a new thymosin analogue restore the impaired immune response in uraemic patients?
Conclusion
The synthetic thymosin analogue [Phe(4F)12]deacetyl-thymosin f14 showed a stronger restorative effect on T-lymphocytes from uraemic patients than the original deacetyl-thymosin f14.
Supporting Evidence
- The synthetic analogue exhibited a stronger restoring effect on T-lymphocytes than the original peptide.
- Thymocytes from uraemic patients showed significantly lower blast formation compared to healthy controls.
- The study demonstrated that modification of the thymosin f14 structure can enhance its biological activity.
Takeaway
Scientists made a new version of a protein that helps the immune system and found it works better than the original in sick patients.
Methodology
The study involved synthesizing a thymosin analogue and testing its effect on T-lymphocytes from uraemic patients using a blast formation test.
Limitations
The study was limited to only two uraemic patients, which may not represent the broader population.
Participant Demographics
Two uraemic patients suffering from recurrent infectious diseases were selected for the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website